Nelson Vergel
Founder, ExcelMale.com
On February 4, 2014, five lawsuits were filed in Illinois federal court against AbbVie Inc., and Abbott Laboratories, Inc., the manufacturers of Androgel, a testosterone therapy treatment. This Androgel lawsuit comes just days after the U.S. Food and Drug Administration (FDA) announced that it is investigating the risk of heart attack, stroke and death in men taking testosterone products.
Plaintiff Claims Manufacturers Misled Consumers
One plaintiff, Kenneth Aurecchia, filed his case (1:14-cv-772) through the United States District Court for the Northern District of Illinois Eastern Division, seeking relief to treat and monitor severe side effects caused by Androgel. Aurecchia claims he was prescribed Androgel for what he thought were symptoms of low testosterone after watching commercials for the product.
He alleges the manufacturers concealed facts about the serious side effects associated with the drug. He also claims he went through physical and emotional damage including suffering from a heart attack.
Plaintiff Claims Manufacturers Misled Consumers
One plaintiff, Kenneth Aurecchia, filed his case (1:14-cv-772) through the United States District Court for the Northern District of Illinois Eastern Division, seeking relief to treat and monitor severe side effects caused by Androgel. Aurecchia claims he was prescribed Androgel for what he thought were symptoms of low testosterone after watching commercials for the product.
He alleges the manufacturers concealed facts about the serious side effects associated with the drug. He also claims he went through physical and emotional damage including suffering from a heart attack.
Last edited:
